Predicting Acute Exacerbations of COPD Using Wearable Devices and Remote Monitoring Technology With AI/ML Models

Launched by MCGILL UNIVERSITY HEALTH CENTRE/RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE · Jan 25, 2025

Keywords

ClinConnect Summary

This clinical trial is looking to improve how we predict flare-ups in Chronic Obstructive Pulmonary Disease (COPD), a lung condition that makes it hard to breathe. Researchers will use two wearable devices—a ring and a wristband—to collect real-time health data from patients in the comfort of their own homes. Participants will also use a handheld device to measure their lung function daily and report any symptoms they experience. This information will help develop smart technology that can predict when a flare-up might occur, allowing for earlier intervention and potentially better management of their condition.

To be eligible for this trial, participants should be at least 40 years old, have a history of smoking, and a diagnosis of moderate to very severe COPD. They should have experienced two or more flare-ups in the past year that required medication. Participants must be able to give their consent and access the internet daily. If you choose to take part, you can expect to wear the devices, provide daily updates about your health, and help researchers learn more about COPD management, which could benefit many patients in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Males/females, age ≥ 40, former/current smokers with ≥10 pack-year smoking history
• • FEV1/FVC \< 0.7, with 80% \< FEV1 ≤50% (moderate, 'GOLD 2') 50% \< FEV1 ≤ 30% (severe, 'GOLD 3') or FEV1 \< 30% (very severe, 'GOLD 4') COPD
• • History of 2 or more exacerbations in the preceding 12 months requiring corticosteroids, antibiotics, or both
• • Ability to provide informed consent
• • Ability to access internet at least once daily
• Exclusion Criteria:
• • No existing COPD diagnosis
• • Any medical/cognitive/functional condition which renders inability to operate research equipment/devices, and/or to complete daily symptom response